Abstract: A compound of Formula (I) or a pharmaceutically acceptable salt thereof, is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.

Abstract: A method of addressing at least one qubit to be addressed in a set of two or more qubits includes exposing the qubit to be addressed to an electromagnetic field; and at a same time exposing another qubit of the set of two or more qubits to an electromagnetic counter field in such a way that the electromagnetic field has no effect on the other qubit or that the electromagnetic field has a different effect on the other qubit than on the qubit to be addressed. A device for performing the method includes the set of two or more qubits and electromagnetic sources for generating the electromagnetic field and electromagnetic counter field.

Abstract: A compound of Formula (I) or a pharmaceutically acceptable salt thereof, is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.

Abstract: The invention provides a compound of formula (1). or tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the various substituents are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds.

Abstract: A rotatable paddle wireless power transfer system provides a robust electric power and data connection between a user and a support vehicle or structure adapted for use in harsh environments. A paddle retention clamp such as a pair of sprung circumferential fingers coupled on either side of a gap into a paddle retainer allows the paddle to be easily removably inserted by a user into the retainer, for example with only a single heavily gloved hand. When the paddle is docked in the paddle retainer, the paddle may be easily rotated relative to the retainer, with up to 90 degrees of rotational freedom so as to provide a non-binding disconnect of the paddle from the paddle retainer during normal or emergency disconnects through 360 degrees of force applied by the user to an electrical umbilical cable affixed to the paddle.

Abstract: A compound of Formula (I) or a pharmaceutically-acceptable salt thereof, is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.

Abstract: A compound of Formula I or a pharmaceutically-acceptable salt thereof, is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.

Abstract: The present invention relates generally to a sensing system for monitoring the state of a system of components, and in particular, to a sensing system for monitoring the state of a system of components and for providing a warning when the state of any component within the system of components requires attention.

Abstract: The invention provides a compound of formula (I): or tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the various substituents are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds.

Abstract: Railcar ramp systems and related methods are disclosed. An example railcar ramp system includes a carriage slidably coupled to a platform via a track guide. A ramp mover assembly is pivotally coupled to the carriage. The ramp mover assembly positionable between a stored position and an active position. In the active position, the ramp mover to enable movement of the carriage in a lateral direction along the track guide.

Abstract: The present disclosure provides a leak monitoring system and associated method which is being configured to detect plumes of volatile organic compounds (VOC) as an alternative solution to the EPA Method 21, which measures VOC concentrations at the surface of each component. The leak monitoring system is a multi-layered system that includes monitoring performed by sensors that are fixed in place and sensors that are mobile. Each monitoring method is a layer and it complements and augments other layers. All the sensors wirelessly communicate with a central control through a gateway. The control unit further includes a software platform, which analyzes the data provided by the sensors in combination with other informetrics such as meteorological conditions and plant info to both identify the presence of a gas leak and to pinpoint a general location of the gas leak.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is described, where the substituents are as defined herein. Pharmaceutical compositions including the same and method of using the same are also described.

Abstract: The present invention provides a compound of formula (1) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Abstract: A housing assembly for an electronic circuit including an electronic control unit (ECU) is a low-profile, generally rectangular device that includes a container, a cover that closes an open end of the container, and a printed circuit board disposed in the housing. The container includes an input electrical connector and an output electrical connector formed at opposed ends of the housing. The output electrical connectors includes electrically conductive pins having an irregular shape and that are partially embedded in the container in such a way that each pin has zero degrees of freedom of movement relative to the container.

Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Abstract: A storage assembly includes top and bottom walls, a pair of end walls extending between the top and bottom walls and cooperating with the top and bottom walls to define an interior space, and at least one end surface configured to closely interfit with at least one end surface of an adjacent storage assembly that is substantially similar to the storage assembly at a predefined angular orientation such that a longitudinal axis of the storage assembly is angularly offset from a longitudinal axis of the adjacent storage assembly when the at least one end surface of the storage assembly is interfit with the at least one surface of the adjacent storage assembly The storage assembly may also include a pair of interior walls and a handle relief extending into the top wall and/or a frame assembly located between one of the end walls and one of the interior walls.

Abstract: The present invention relates to compounds which are of use in the field of agriculture as fungicides.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.

Abstract: Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.